Moncyte Health is developing a patented technology to optimize the treatment and prevention of cardiovascular disease.
Moncyte Health has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Moncyte Health's investors include Inventure, Business Finland, University of Helsinki, Almaral, Athensmed.
Moncyte Health is headquartered in Helsinki, Finland.
Moncyte Health is developing a patented technology to optimize the treatment and prevention of cardiovascular disease.
Moncyte Health is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moncyte Health — Funding & Investors." VCBacked, October 8, 2024, https://www.vcbacked.co/company/moncyte-health. Accessed July 19, 2026.
VCBacked. (2024). Moncyte Health — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/moncyte-health
{{cite web |title=Moncyte Health — Funding & Investors |url=https://www.vcbacked.co/company/moncyte-health |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated